What We're Reading: Page 306
Industry reads hand-picked by our editors
May 01, 2017
Apr 28, 2017
-
The Washington Post
More than a million patients flock to this website. Drug companies are in hot pursuit.
-
Reuters
South Korea fines Novartis $49 million over kickbacks, suspends insurance payment
-
Vox
Google is super secretive about its anti-aging research. No one knows why.
-
MobiHealthNews
With $10M from Sanofi-Genzyme BioVentures, Evidation Health sets sights on pharma
Apr 27, 2017
-
Kaiser Health News
Negotiating drug prices: Should state agencies band together?
-
Regulatory Focus
Supreme Court weighs biosimilar patent dance
-
Smithsonian
Keeping vaccines safe in tiny "cages"
-
NPR
Welcome to the poison garden: Medicine's medieval roots
Apr 26, 2017
-
The New York Times
The C.E.O. of H.I.V.
-
Axios
Here's who is spending the most on health care lobbying
-
Financial Times
WHO steps closer to eliminating tropical disease
-
Forbes
Four decades of hacking biotech and yet biology still consumes everything
Apr 25, 2017
-
Reuterds
NASH: The next untapped pharma market gives investors many options
-
MIT Technology Review
Immunotherapy pioneer James Allison has unfinished business with cancer
-
The Wall Street Journal
Novartis tests new Alzheimer's drug on people who don't have the disease
-
Bloomberg
Billionaire doctor's $11,000 cancer test has few takers so far
Apr 24, 2017
-
Financial Times
Sanofi plays down need for pharma deals
-
The Guardian
WHO, Pfizer seek acceleration of global access to vaccines
-
The Wall Street Journal
QuintilesIMS in deal to use Salesforce.com’s cloud technology
-
Forbes
Hiding data and other criticisms of big pharma
Apr 21, 2017
-
Bloomberg
Biotech M&A falls off as Trump dashes hopes of a new pharma boom
-
The Guardian
Sanofi epilepsy drug linked to over 4,000 child deformities
-
Chicago Tribune
$3 million awarded to widow who sued pharmaceutical firm over husband's suicide
-
Kaiser Health News
With drug costs in crosshairs, health firms gave generously to Trump’s inauguration
Previous
